Clinical relevance: Vitamin C backed to shorten ICU stays

By Nathan Gray

- Last updated on GMT

©Getty Images
©Getty Images
Oral supplementation with vitamin C at an average dose of two grams per day could significantly cut the length of time of stays in intensive care units, according to a new meta-analysis of clinical trial data.

The study, published in Nutrients​, notes that previous evidence shows vitamin C supplementation may have a plethora of benefits which may cumulatively impact metabolism ad overall health.

Indeed, in previous clinical trials vitamin C has been found to lower blood pressure, decrease the incidence of atrial fibrillation, decrease broncho-constriction, decrease pain, decrease glucose levels in patients with type 2 diabetes, and shorten the duration of colds.

However, it is the potential benefit in for hospital stays that the authors focused on – noting that it is not uncommon for patients in hospital, and particularly those in intensive care units (ICU) to have very low vitamin C levels.

Dr Harri Hemilä from the University of Helsinki, Finland, and Dr Elizabeth Chalker from the University of Sydney, Australia, noted that a recent study of elderly Scottish patients hospitalised because of acute respiratory infections reported that 35% of patients had vitamin C plasma levels less than 11 μmol/L – which is the level at which scurvy becomes a risk.

“One study in a hospital in Paris reported that 44% of patients had vitamin C plasma levels less than 6 μmol/L,”​ noted the pair. “Another survey, of patients with advanced cancer in a hospice, found that 30% had vitamin C plasma levels less than 11 μmol/L.”

“Given this, it would seem reasonable to screen plasma vitamin C levels in hospital patients when appropriate and administer vitamin C to patients with particularly low levels,” they said.

Hemilä and Chalker added that although 0.1 grams per day of vitamin C can maintain a normal plasma level in healthy persons, much higher doses of up to 4 grams per day, are needed for critically ill patients to increase their plasma vitamin C levels to the range of normal healthy people.

Therefore, high vitamin C doses may be needed to compensate for the increased metabolism in critically ill patients.

Meta-analysis

The pair of researchers set out to analyse data from previously published clinical trials, in order to assess what benefit – if any – supplementation with vitamin C actually has on patients who are critically ill.

They identified 18 relevant controlled trials, and 12 of which were included in the meta-analysis on the length of stay.

Analysis of data the pooled data showed that on average, vitamin C administration shortened ICU stay by 7.8%.

Furthermore, they reported that in six trials, orally administered vitamin C with an average dose of 2 grams per day reduced the length of ICU stay on average by 8.6%.

“In three trials in which patients needed mechanical ventilation for over 24 hours, vitamin C shortened the duration of mechanical ventilation by 18.2%,”​ they added.

“Given the insignificant cost of vitamin C, even an 8% reduction in ICU stay is worth exploring,”​ they commented – adding that the effects of vitamin C on ICU patients should be investigated in more detail.

They said that further studies are needed to find optimal protocols for its administration – adding that a few studies of the common cold studies have also suggested there may be a linear dose response for vitamin C and duration for up to 6 and 8 grams per day.

“Evidently the dose response for doses higher than 2 grams per day should also be investigated for ICU patients,”​ they added.

Source: Nutrients
Volume 11, Number ​4, Page 708, Open Access, doi: 10.3390/nu11040708
“Vitamin C Can Shorten the Length of Stay in the ICU: A Meta-Analysis”
Authors: Harri Hemilä, ​Elizabeth Chalker

Related topics Research Healthy ageing

Related news

Related products

show more

Embrace Active Aging and ENJOY life!

Embrace Active Aging and ENJOY life!

Content provided by IFF | 05-Sep-2024 | Product Brochure

Live life to the fullest, regardless of age. Our science-backed formulas, packed with clinically studied probiotics and botanicals, empower you to age...

From Biofarma a clinically tested vaginal protection

From Biofarma a clinically tested vaginal protection

Content provided by Biofarma Group | 05-Sep-2024 | Product Brochure

Bacterial vaginosis is considered the most common cause of vaginal infection among pregnant and non-pregnant women. In this scenario, the oral intake of...

Giellepi finds evidence of bromelain adulteration

Giellepi finds evidence of bromelain adulteration

Content provided by Giellepi SpA | 03-Sep-2024 | Product Brochure

As demand for botanicals continues to increase, unethical suppliers try to maximize profitability offering adulterated raw materials.

Related suppliers

Follow us

Products

View more

Webinars